To further explore TET2 expression in GBM cell subsets, we analyzed scRNA-Seq expression data from GBM clinical samples using the BioTouring browser.25 This analysis revealed that only a small fraction of cells expressing SOX2, a transcriptional driver of GBM stemness, expressed TET2 (Fig. 1d). Here, TET2 is linked to glioblastoma.